AP-005 (Altum)

N/A

Report date: 2025/01/26 16:54:00

Base Information

Drug NameAP-005 (Altum)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionEpidermal growth factor receptor erbB1 modulators
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsPsoriasisDermatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAltum Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAltum Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsPsoriasisDermatitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A